On Monday, Metagenomi Inc (NASDAQ: MGX) opened lower -4.17% from the last session, before settling in for the closing price of $3.24. Price fluctuations for MGX have ranged from $1.61 to $12.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 3569.20%. Company’s average yearly earnings per share was noted 87.64% at the time writing. With a float of $18.78 million, this company’s outstanding shares have now reached $37.43 million.
Let’s determine the extent of company efficiency that accounts for 236 employees. In terms of profitability, gross margin is 93.13%, operating margin of -160.63%, and the pretax margin is -137.13%.
Metagenomi Inc (MGX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Metagenomi Inc is 49.81%, while institutional ownership is 24.81%. The most recent insider transaction that took place on Dec 05 ’24, was worth 2,900. In this transaction Chief Financial Officer of this company sold 1,559 shares at a rate of $1.86, taking the stock ownership to the 61,492 shares. Before that another transaction happened on Sep 05 ’24, when Company’s Chief Financial Officer sold 6,265 for $2.88, making the entire transaction worth $18,043. This insider now owns 63,051 shares in total.
Metagenomi Inc (MGX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 87.64% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Check out the current performance indicators for Metagenomi Inc (MGX). In the past quarter, the stock posted a quick ratio of 6.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.66 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Looking closely at Metagenomi Inc (NASDAQ: MGX), its last 5-days average volume was 3.67 million, which is a jump from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 50.86%. Additionally, its Average True Range was 0.47.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 45.17%, which indicates a significant increase from 41.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 352.49% in the past 14 days, which was higher than the 151.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.18, while its 200-day Moving Average is $4.94. However, in the short run, Metagenomi Inc’s stock first resistance to watch stands at $3.37. Second resistance stands at $3.63. The third major resistance level sits at $3.85. If the price goes on to break the first support level at $2.88, it is likely to go to the next support level at $2.65. Now, if the price goes above the second support level, the third support stands at $2.39.
Metagenomi Inc (NASDAQ: MGX) Key Stats
There are currently 37,424K shares outstanding in the company with a market cap of 97.53 million. Presently, the company’s annual sales total 44,760 K according to its annual income of -68,260 K. Last quarter, the company’s sales amounted to 11,510 K and its income totaled -18,770 K.
